drugset / Trial / NCT01420328

To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects

NCT01420328

RandomizedParallel-groupTriple-blindBasic science

Summary

This study focuses on the use of Vytorin to study inflammatory markers in subjects with normal cholesterol.

Timeline

Start
2011-05-01
Primary completion
2015-07-01
Completion
2016-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ezetimibe Unknown 10 mg
Comparator Simvastatin Small molecule 40 mg

Indications

No indication recorded.